| Characteristic | Invoice price | Estimated net price** |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Sources
Release date
December 2020
Region
United States
Survey time period
2011 to 2019
Supplementary notes
* Includes protected brand medicines only (ie, brand medicines without generic versions available in the year indicated).
** Estimated net price growth reflects impact of off-invoice rebates and discounts provided by manufacturers.
Citation formats









